Advertisement

Topics

Companies Related to "genehmigt erweiterte Indikation Novartis Krebsmittel Zykadia" [Most Relevant Company Matches] RSS

05:02 EST 15th December 2017 | BioPortfolio

Here are the most relevant search results for "genehmigt erweiterte Indikation Novartis Krebsmittel Zykadia" found in our extensive corporate database of over 50,000 company records.

Showing "genehmigt erweiterte Indikation Novartis Krebsmittel Zykadia" Companies 1–25 of 89

Relevant

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In ...


Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the patients and physicians. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, pr...


Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...

Idenix Pharmaceuticals

Idenix is pursuing a disciplined business strategy that seeks to capitalize upon the diverse expertise of the company’s management team. While Idenix is focused on bringing its late-stage product candidates to market, it also believes that maintaining a full pipeline of drug candidates with the potential to become first- or best-in-class therapies for large and growing markets is critical to its...

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). Since the very beginning, Novartis Venture Fund (part of the worldwide life science company Novartis International AG) is a main customer for which Venture Valuation carries out all external ...

MyoPowers Medical Technologies SA

MyoPowers Medical Technologies, formerly known as Nanopowers, was founded by Dr Piergiorgio Tozzi of the University Hospital of Lausanne (CHUV) and Professor Daniel Hayoz of the Cantonal Hospital of Fribourg and the CHUV. In 2009, the company was selected as one of the best innovative medical technology companies by the Swiss Commission for Technology and ...

Novartis Oncology

Probably Relevant

AICOS Technologies AG

After the announcement in March 1996 by the two large pharmaceutical companies, Ciba-Geigy AG and Sandoz AG, of their intention to merge and form a new company, Novartis, it soon became clear that parts of this company would be "outsourced". The so-called Novartis Venture Fund was created to help the creation of small high-tech companies in the process of the merger. AICOS Technologies AG is one o...

Genomics Institute of the Novartis Research Foundation

The Genomics Institute of the Novartis Research Foundation (GNF) has integrated state of the art technologies, making possible new approaches to complex biomedical problems in the neurosciences, immunology and cancer biology. These technologies cut across the life sciences and include genomics and proteomics tools, combinatorial chemistry, structural genomics and computational biology. The mission...

Syngenta

Syngenta is a new company, with a proud history.Syngenta was formed in late 2000, bringing together the strengths of Novartis Agribusiness and Zeneca Agrochemicals to create a new global company with an exclusive focus on agribusiness.

Sandoz International GmbH

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredients.In 2005, Sandoz acquired Hexal, one of Germany’s leading generics company, and Eon Labs, one of the fastest-growing generic pharmaceuticals companies in the US. These acquisitions significantly s...

Neovacs S.A.

Neovacs is a French biotechnology company focused on active immunotherapy for autoimmune and inflammatory diseases and cancer. Neovacs is a spin-off from Université Pierre et Marie Curie in Paris, founded in 1993 by the French immunologist Daniel Zagury, MD-PHD. Neovacs is a French biotechnology company focused on active immunotherapy for autoimmune and inflammatory diseases. Using its ...

Idera Pharmaceuticals

We are a biotechnology company engaged in the discovery and development of novel therapeutics that modulate immune responses through Toll-like receptors (TLR) for the treatment of multiple diseases.Idera Pharmaceuticals’ business strategy is to advance its clinical-stage cancer programs and to develop other applications of its technology through new partnerships. We currently are collaborating w...

Intrasphere

Intrasphere is headquartered in New York City. Our US office provides comprehensive consulting services including strategy, application development, systems integration & customization, validation compliance and production support to companies such as Pfizer, Merck, Eli Lilly and Novartis among others. By taking the time to understand your business, people, culture and objectives, we deliver supe...

RMi

RMi, headquartered in Des Moines, Iowa and with offices in New York City and Thousand Oaks, Calif., is a multi-channel marketing consultancy focused on the pharmaceutical and biotechnology industries. Since 2006, it has worked in more than 30 therapeutic classes, including anti-infectives, allergy, cardiovascular, oncology, infused products and vaccines. A...

Euro RSCG Life

Euro RSCG Life aligns the company's 60 health-focused agencies into a network with more than 2,000 employees, offering advertising, public relations, event promotion, medical education, digital marketing, direct-to-patient and consulting services. Its client roster includes Biogen Idec, Novartis, Pfizer, sanofi-aventis, Shire, EMD Serono, Bristol-Myers Squibb and Merck. For more information, visit...

EquipNet

EquipNet is a leading provider of proactive asset management solutions and services to leading corporations in the biotech, pharmaceutical, chemical, food, beverage, and personal care industries, such as Novartis, Johnson and Johnson, Sanofi Aventis, Merck and many others. EquipNet’s vision is to revolutionize the way companies manage their surplus as...

NCS Technologies

"Innovating." "Solutions."These two words have described NCS Technologies throughout our over two decades of experience.Solving problems in corporate systems environments. Creating solutions for business challenges through hundreds of successful projects. Innovating the effective use of technology for some of the world’s leading businesses.AT&T. Aventis. AT&T Wireless. Bayer. Bristol-Myers ...

EyeSense AG

EyeSense(TM) AG is a venture-backed diagnostic device company based in Basel, Switzerland, and with operations near Frankfurt am Main, Germany. EyeSense was founded in 2006 as a spinout from Ciba Vision AG (a Novartis company), and develops ophthalmic diagnostic systems focusing on glucose testing for diabetic patients. In addition to glucose, the testing platform being developed by EyeSense h...

Bicycle Therapeutics Ltd

Bicycle Therapeutics is a biotechnology company based at the Babraham Research Campus in Cambridge, U.K. developing a novel technology for the creation of a new generation of biotherapeutics which combine the desirable features of small molecules and biopharmaceuticals. Bicycle technology is based on the work performed at the MRC Laboratory of Molecular...

Proteus Digital Health, Inc.

Proteus Digital Health, formally known as Proteus Biomedical, Inc., believes in better health, powered by you. Proteus’s wearable and ingestible sensor technology is used to deliver digital medications and other health and wellness products. Headquartered in Redwood City, CA, Proteus partners with and licenses to leading companies to commercialize dig...

NewsGator Technologies, Inc.

NewsGator makes SharePoint social. Our Enterprise 2.0 software suite, Social Sites, boosts any organization's performance with the power of innovation management, collaboration and knowledge-sharing both inside the enterprise and out. Customers achieving results with Social Sites include Accenture, Battelle, Biogen Idec, CME Federal Credit Union, Deloitte, Edelman, Fujitsu, Merck, Novartis, The Un...

Avila Therapeutics, Inc.

Avila focuses on design and development of targeted covalent drugs to achieve best-in-class outcomes that cannot be achieved through traditional chemistries. This approach is called “protein silencing”. The company’s product pipeline has been built using its proprietary Avilomics™ platform and is currently focused on viral infection, cancer ...

Tokai Pharmaceuticals, Inc.

Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The company’s lead drug candidate, galeterone (TOK-001), is the first investigational new drug that can decrease overall androgen receptor levels in prostate tumors and in which three distinct mechanisms of action are combined in one onc...


More From BioPortfolio on "genehmigt erweiterte Indikation Novartis Krebsmittel Zykadia"

Quick Search
Advertisement
 

Corporate Database Quicklinks